RYTMILEN

Main information

  • Trade name:
  • RYTMILEN 0.8 mg/ ml intravenous infusion
  • Dosage:
  • 0.8 mg/ ml
  • Pharmaceutical form:
  • intravenous infusion
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • RYTMILEN 0.8 mg/ml intravenous infusion
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Disopyramide

Status

  • Source:
  • Fimea
  • Authorization status:
  • MA withdrawn after authorization
  • Authorization number:
  • 8647
  • Authorization date:
  • 22-02-1989
  • Last update:
  • 20-02-2018